title: TMC125: new results, large phase III trial begins.
abstract: New data, new trials on "2nd generation" experimental NNRTI much less subject to viral resistance than efavirenz or nevirapine.
authors.forename: John S
authors.initials: JS
authors.lastname: James
mesh_terms: D006801:Humans; D009570:Nitriles; D011724:Pyridazines / Q000627:therapeutic use*; D011743:Pyrimidines; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D019562:Viral Load
chemical_list: D009570:Nitriles; D011724:Pyridazines; D011743:Pyrimidines; D018894:Reverse Transcriptase Inhibitors; C451734:etravirine